Abstract
To determine why incidence of mucormycosis infections was increasing in a large university hospital in Belgium, we examined case data from 2000-2009. We found the increase was not related to voriconazole use but most probably to an increase in high-risk patients, particularly those with underlying hematologic malignancies.
MeSH terms
-
Adolescent
-
Adult
-
Aged
-
Antifungal Agents / adverse effects
-
Belgium / epidemiology
-
Child
-
Female
-
Hematologic Neoplasms / complications
-
Hospitals, University
-
Humans
-
Incidence
-
Male
-
Middle Aged
-
Mucormycosis / epidemiology*
-
Mucormycosis / etiology
-
Pyrimidines / adverse effects
-
Risk Factors
-
Triazoles / adverse effects
-
Voriconazole
-
Young Adult
Substances
-
Antifungal Agents
-
Pyrimidines
-
Triazoles
-
Voriconazole